Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
1 competing product in clinical development for Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Nivolumab + Everolimus | Ono Pharmaceutical | Phase 3 | Completed | 40 |